President Trump’s opioid commission last week focused on health insurance companies’ role in contributing to the addiction crisis. The commission is scheduled to deliver its final report on November 1.
Representative Tom Marino of Pennsylvania announced this week he is withdrawing his name from consideration as head of the White House Office of National Drug Control Policy. His decision comes in the wake of a Washington Post and 60 Minutes joint report that concluded legislation Marino sponsored hampered efforts by the Drug Enforcement Administration to fight the opioid epidemic.
Health insurer Cigna announced this week it will stop covering the prescription opioid OxyContin in an effort to reduce inappropriate use of the drug. Instead it will cover an equivalent drug less vulnerable to being misused.